upgrade

Morgan Stanley Adjusted Its 2011, 2012 EPS Estimates For OpenTable, Maintained Its EW Rating

The bank sees 2011 EPS of $0.77, down from $0.86 per share, and 2012 EPS of $1.28, up from $1.12 per share.

OpenTable is currently above its 50-day moving average (MA) of $75.14 and above its 200-day of $57.89.

opentable, restaurant, reservation, buy, sell, stock, trade, invest, roi, return, margin, profit, revenue, analyst, upgrade, downgrade, price, target, market, sector, industry, rating, report, research, eps, moving average, morgan stanley, NASDAQ:OPEN

Morgan Stanley adjusted its 2011 and 2012 EPS estimates for OpenTable (NASDAQ:OPEN) and maintained its equal-weight rating.

By Christie Duffy
cduffy@fnno.com

Stratasys Shares up 11.30% on 80% Increase in Q4 Profit

The company posted record revenue of $33.8 million for the fourth quarter ended Dec. 31, a 29% increase over the $26.2 million reported for the same period in 2009. Net income was $4.3 million for the fourth quarter, or $0.20 per

advice, analyst, average, balance, bank, billion, business, company, down, downgrade, earnings, economy, eps, estimate, expecton billion quarter year fiscal finance business economy roi return invest advice balance sheet net income gross margin result report research analyst firm bank company stock share trade up down upgrade downgrade trend percent industry sector average, finance, firm, fiscal, gross, income, industry, invest, margin, million, net, percent, quarter, report, research, result, return, reuters, revenue, roi, sector, share, sheet, stock, trade, trend, up, upgrade, year

Shares of Stratasys (SSYS) are up $4.80 to $40.18, or 11.61%, after the company reported strong fourth quarter and full year financial results that surpassed market expectations.

By Christie Duffy
cduffy@fnno.com

Morgan Stanley Lowered its 2011, 2012 EPS Estimates For Teva Pharmaceutical Industries (TEVA)

teva, pharmaceutical, pills, prescription, medicine, heal, earn, buy, sell, upgrade, downgrade, share, stock, market, price, target, analyst, research, report, firm, bank, industry, sector, business, finance, invest, advice, money, dollar, million, billion, up, down, equal-weight, rating

Morgan Stanley lowered its 2011 and 2012 EPS estimates for Teva Pharmaceutical Industries (NASDAQ:TEVA) and maintained its equal-weight rating. The bank sees 2011 EPS of $5.05, down from $5.29 per share, and 2012 EPS of $5.78, do

By Christie Duffy
cduffy@fnno.com

Morgan Stanley Lowered Its EPS Estimates For Sara Lee, Maintained Its EW Rating (SLE)

moving, average, stock, price, ticker, market, trade, earn, profit, net, gross, margin, analyst, action, report, upgrade, downgrade, research, advise, invest, money, cash, dollar, NYSE, SLE, NYSE:SLE, NASDAQ, food, stock, sector, morgan, stanley, bank, firm

Morgan Stanley lowered its 2011 and 2012 EPS estimates for Sara Lee (NYSE:SLE) and maintained its equal-weight rating and $14.50 price target. The bank sees 2011 EPS $0.85, down from $0.89 per share, and 2012 EPS of $1.00, down fr

By Christie Duffy
cduffy@fnno.com

ThinkEquity Downgrades Dick's Sporting to Hold - Shares Down 1.8%

The firm made the call based on valuation and a likely difficult Q4 due to weather and tax refund delays.

Dick's Sporting is down nearly 2% early Wednesday on the news, at $37.55.

dick's, sporting, retail, DKS, trade, stock, swap, earn, buy, sell, hold, buy, rating, credit, analyst, finance, financial, thinkequity, downgrade, upgrade, firm, call, valuation, Q4, quarter, margin, profit, revenue, earnings, EPS, tax, refund, net, income

Shares of Dick's Sporting (DKS) are down in pre-market trading as the company was reportedly downgraded to Hold from Buy at ThinkEquity.

By Christie Duffy
cduffy@fnno.com

Morgan Stanley Raised Its 2011 EPS Estimate For Illumina, Maintained Its OW Rating

The bank sees 2012 EPS of $1.98, up from $1.97 per share.

Illumina has a potential upside of 5% based on a current price of $70.25 and an average consensus analyst price target of $73.73.

Illumina is currently above its 50-day moving average (MA) of $66.13 and above its 200-day of $51.55.

Morgan, Stanley, bank, earnings, upgrade, downgrade, finance, business, stock, moves, money, earn, buy, sell, trend, up, down, price, target, analyst, firm, illumina, NASDAQ:ILMN, NASDAQ, NYSE, rating, credit, overweight, underweight, research, report, eps, revenue, margin, gross, profit, loss, balance, financial, share, dollar, million, billion

Morgan Stanley raised its 2012 EPS estimate for Illumina (NASDAQ:ILMN) and maintained its overweight rating and $78 price target.

By Christie Duffy
cduffy@fnno.com

Latest News from FNNO

Shares of Zimmer Have Risen Above Previo...

Shares of Zimmer (NYSE:ZMH) traded today at $81.92, breaking its 52-week high. This ne ...

Shares of Zions Bancorporation Rise Abov...

Shares of Zions Bancorporation (NASDAQ:ZION) traded today at $28.00, breaking its 52-we ...

Shares of Crosstex Energy Rise Above Pre...

Shares of Crosstex Energy (NASDAQ:XTEX) traded at a new 52-week high today of $21.31. ...

Xilinx: The Winning Streak Continues (XL...

Shares of Xilinx (NASDAQ:XLNX) traded at a new 52-week high today of $39.88. So far to ...

Shares of Weyerhaeuser Rise to a New 52-...

Weyerhaeuser (NYSE:WY) traded at a new 52-week high today of $33.24. This new high was ...

Watch for Continued Gains in Shares of W...

Shares of Wolverine World Wide (NYSE:WWW) traded at a new 52-week high today of $53.97. ...

Washington Real Estate Investment Trust ...

Shares of Washington Real Estate Investment Trust (NYSE:WRE) traded at a new 52-week hi ...

Shares of WPX Energy Have Risen Above Pr...

WPX Energy (NYSE:WPX) traded today at a new 52-week high of $21.10. So far today appro ...

Most Popular Video News